ZIPRASIDONE ACTAVIS ziprasidone (as hydrochloride) 40 mg capsule blister pack

Pays: Australie

Langue: anglais

Source: Department of Health (Therapeutic Goods Administration)

Ingrédients actifs:

ziprasidone hydrochloride, Quantity: 43.44 mg (Equivalent: ziprasidone, Qty 40 mg)

Disponible depuis:

Medis Pharma Pty Ltd

DCI (Dénomination commune internationale):

Ziprasidone hydrochloride

forme pharmaceutique:

Capsule, hard

Composition:

Excipient Ingredients: Gelatin; pregelatinised maize starch; magnesium stearate; indigo carmine; croscarmellose sodium; titanium dioxide; colloidal anhydrous silica

Mode d'administration:

Oral

Unités en paquet:

60

Type d'ordonnance:

(S4) Prescription Only Medicine

indications thérapeutiques:

for the treatment of schizophrenia, related psychoses, prevention of relapse and for maintenance of clinical improvement during continuation therapy;,as monotherapy for the short term treatment of acute manic or mixed episodes associated with bipolar I disorder.

Descriptif du produit:

Visual Identification: size 4 capsule: blue body, blue cap; Container Type: Blister Pack; Container Material: PA/Al/PVC/Al - polyamide-aluminium foil-polyvinylchloride/aluminium foil; Container Life Time: 36 Months; Container Temperature: Store below 30 degrees Celsius; Container Closure: Child resistant closure

Statut de autorisation:

Licence status A

Date de l'autorisation:

2015-03-05